NOF America Corporation is a distinguished supplier to the pharmaceutical industry, specialising in the manufacture of high purity Methoxy polyethylene glycols (mPEGs), with molecular weights ranging from 2kDa to 80kDa. The company produces activated PEG derivatives, including methoxy PEG amines, maleimides, and carboxylic acids. As a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO), NOF America supports diverse applications in the fields of excipients, cell therapy, and gene therapy.

One of the key aspects of NOF America Corporation's offerings is its commitment to delivering high-quality products tailored to meet the needs of the pharmaceutical sector.

Services include:
- Manufacturing of high purity Methoxy polyethylene glycols (mPEGs)
- Production of activated PEG derivatives
- Custom chemical synthesis
- Formulation development
- Support for contract manufacturing and development projects

With its advanced capabilities, NOF America Corporation is poised to play an integral role in the evolving pharmaceutical landscape, contributing to the development of innovative therapies. For further details, please visit nofamerica.com.